SecBot SecBot
8-K ·Filed Aug 28, 2026

SRXH

SRX Global Inc.
BEARISH
Impact 5/10
Horizonweeks Processed2mo ago SEC0001493152-26-040642
Killer combo: Material agreement + unregistered equity (likely PIPE/convertible)
Actionable Insight ▼ Bearish

The non-cash exchange of CERO notes for convertible preferred stock adds a large dilutive overhang with no operating cash infusion. Monitor for stockholder approval timeline and any early conversion activity that could pressure the stock. The alternate conversion rights at a discount to VWPA create a structural downward bias if the stock trades below $2.1888.

DirectionBearish
Confidencemedium
Horizonweeks

How the stock moved after the report

BEARISH VIEWSTOCK BELOW ENTRY AT T+20
Entry
$1.68
T+0 close · Aug 28, 2026 · via day close
Latest settled
−0.60%
T+20 · $1.67 · next T+60 tomorrow
Vs SPY
−0.66%
α at T+20
Latest observation
−6.67%
T+58 · FF3 residual α
  1. T+0 · Aug 31 $1.68entry
  2. T+1 · 3mo ago −2.98%α −2.29% · $1.63
  3. T+5 · 3mo ago −5.65%α −5.51% · $1.59
  4. T+20 · 8w ago −0.60%α −0.66% · $1.67
  5. T+58 · todayOpen
  6. T+60 · tomorrow Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

SRX Global issued $2.86M of Series C convertible preferred stock to accredited investors in exchange for assignment of CERO Therapeutics promissory notes, with no new cash proceeds. The preferred stock carries a fixed conversion price of $2.1888 per common share and includes alternate conversion rights at a discount to market price after stockholder approval, creating significant future dilution overhang.

Key Financial Metrics

Offering Size
$2.9M

Key Facts

  • Sold 3,579 shares of Series C convertible preferred stock at $1,000 stated value per share for total consideration of $2,862,500
  • Purchase price satisfied by assignment of Convertible Grid Promissory Notes issued by CERO Therapeutics Holdings, Inc. (aggregate original principal $2,812,500)
  • Fixed conversion price of $2.1888 per common share; alternate optional conversion at 95% of 5-day VWAP and alternate triggering event conversion at 90% of 5-day VWAP (both after stockholder approval)
  • Company must seek stockholder approval for issuance of all common shares upon conversion and warrant exercise per NYSE American rules
  • Registration rights agreement requires filing of resale registration statement for conversion shares and warrant shares
  • Company may redeem all outstanding Series C preferred at 115% of the greater of conversion amount or market-linked value

Financial Impact

Up to ~1.6M common shares issuable upon full conversion of Series C preferred at $2.1888/share, representing material dilution relative to current $35M market cap

dilutionshare countcapital structure

Risk Factors

  • Significant dilution from conversion of Series C preferred into common stock
  • Alternate conversion at 95%/90% of VWPA could accelerate selling pressure
  • No new cash raised, the transaction merely swaps one illiquid asset for equity-linked securities
  • Stockholder approval required for full conversion rights; failure could trigger triggering events with penalty provisions

Market Snapshot

Exchange
NYSE
Sector
Beverages
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Consumer & Retail

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-040642
Document: 0001493152-26-040642-index.html0001493152-26-040642
Document: 0001493152-26-040642.txt0001493152-26-040642

Track record

30 reports on SRXH

Performance horizon

3 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +77.11% at T+60 after the Jun 18, 2026 report. 3 of 5 went positive at some point.

Filters
  1. Nov 20, 20261d ago Press Release Neutral 3/10 Entry $0.8402 Now $0.8000 −4.78% settles Nov 30
  2. Nov 20, 20261d ago SC 13D Neutral 5/10 Entry $0.9950 Now $0.8000 −19.60% settles Nov 30
  3. Oct 30, 202622d ago Press Release Neutral 3/10 Entry $1.01 to $0.8116 Now $0.8000 −20.79% ▼ −19.64% −16.94% vs SPY
  4. Oct 7, 20266w ago 8-K Mixed 6/10 Entry $1.49 to $1.29 Now $0.8000 −46.31% ▼ −13.42% −12.44% vs SPY
  5. Oct 6, 20266w ago 8-K Neutral 4/10 Entry $1.49 to $1.29 Now $0.8000 −46.31% ▼ −13.42% −12.44% vs SPY
  6. Sep 24, 20268w ago Press Release Neutral 3/10 Entry $1.73 to $1.61 Now $0.8000 −53.76% ▼ −6.94% −6.52% vs SPY
  7. Sep 9, 202610w ago 8-K Neutral 3/10 Entry $1.51 to $1.60 Now $0.8000 −47.02% ▲ +5.96% +6.62% vs SPY
  8. Sep 2, 202611w ago 8-K Neutral 5/10 Entry $1.56 to $1.59 Now $0.8000 −48.72% ▲ +1.92% +3.07% vs SPY
  9. Aug 28, 202612w ago 8-K Bearish 5/10 Viewing Entry $1.68 to $1.59 Now $0.8000 +52.38% ▲ +5.65% +5.51% vs SPY
  10. Aug 19, 202613w ago 8-K Mixed 5/10 Entry $1.87 to $1.84 Now $0.8000 −57.22% ▼ −1.60% −1.22% vs SPY
Showing 10 of 30

US Market Status

Market Closed · Opens Mon (26h 4m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 28, 2026